Aboud, 2017. Study of the Efficacy of Triple Therapy of Sofosbuvir, Pegylated INFalpha 2a and Ribavirin in Treatment of Chronic Hepatitis C Patients Genotype 4 with High Fibrosis 07.. https://doi.org/10.4236/ojgas.2017.71002